Bendamustine is a chemotherapy cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat B-cell non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). It is also being studied in the treatment of other types of cancers, including multiple myeloma.
SparkCures ID | 41 |
---|---|
Developed By | Teva Pharmaceuticals |
Generic Name | Bendamustine |
Additional Names | Treanda, SDX-105 |
Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.